Grant: Collaborative Health Research Projects
University of Toronto
$199,496.00
Rescue Electrical Conduction of Heart Scar Tissue to Diminish Cardiac Arrhythmia
EF 2019-20
Résumé
Heart attacks and heart failure are the main causes of disability and death around the worldand in Canada. After a heart attack, the death of muscle cells causes a scar to form in theheart. This scar stops the normal path of electrical signals that allows the heart to beat in acoordinated fashion to efficiently eject blood from the heart. In addition, the disrupted signalscan induce extra inefficient heart beats (arrhythmia). Patients with abnormal conduction orarrhythmias often need a pacemaker, but electrical stimulation of the heart from thepacemaker disrupts the normal beating sequence and induces dysfunction of the heart. Bothheart attack and the electrical stimulation result in abnormal signal conduction in the heart.We will create new conductive biomaterials which will repair the heart and properly conductelectrical signals across the scar following a heart attack. The new materials will enhance thetransmission of electrical signals that control the pumping of the heart. The goal is to restorethe normal pattern of coordinated heart contraction for heart diseases described above. Onebiomaterial is a gel that will be injected into the scar tissue to improve the electrical signalingpropagation of the heart. The second biomaterial is a membrane which will be applied to thesurface of the damaged heart. Our new materials are unique because they will facilitateelectrical conduction and keep the heart beating synchronously. We will measure how wellthe gel and the membrane conduct electrical signals and how well they coordinate the heartbeats.Our aim is to provide a new treatment for cardiac patients that will be more effective thancurrent therapies. This new approach could allow patients to return to their normal lifestyleand remain active without the need of a pacemaker. The overall impact of our proposedresearch is to improve the quality of life for patients, and reduce the burden of heart diseasefor both patients and the healthcare system.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
523668-2018
Name nom
Li, RenKe
Department département
Surgery
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
199496
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Rescue Electrical Conduction of Heart Scar Tissue to Diminish Cardiac Arrhythmia
Keyword
NSERC
Application summary
Heart attacks and heart failure are the main causes of disability and death around the worldand in Canada. After a heart attack, the death of muscle cells causes a scar to form in theheart. This scar stops the normal path of electrical signals that allows the heart to beat in acoordinated fashion to efficiently eject blood from the heart. In addition, the disrupted signalscan induce extra inefficient heart beats (arrhythmia). Patients with abnormal conduction orarrhythmias often need a pacemaker, but electrical stimulation of the heart from thepacemaker disrupts the normal beating sequence and induces dysfunction of the heart. Bothheart attack and the electrical stimulation result in abnormal signal conduction in the heart.We will create new conductive biomaterials which will repair the heart and properly conductelectrical signals across the scar following a heart attack. The new materials will enhance thetransmission of electrical signals that control the pumping of the heart. The goal is to restorethe normal pattern of coordinated heart contraction for heart diseases described above. Onebiomaterial is a gel that will be injected into the scar tissue to improve the electrical signalingpropagation of the heart. The second biomaterial is a membrane which will be applied to thesurface of the damaged heart. Our new materials are unique because they will facilitateelectrical conduction and keep the heart beating synchronously. We will measure how wellthe gel and the membrane conduct electrical signals and how well they coordinate the heartbeats.Our aim is to provide a new treatment for cardiac patients that will be more effective thancurrent therapies. This new approach could allow patients to return to their normal lifestyleand remain active without the need of a pacemaker. The overall impact of our proposedresearch is to improve the quality of life for patients, and reduce the burden of heart diseasefor both patients and the healthcare system.